Susceptibility of pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance

Current Microbiology

Volumn 64, Issue 1, 2012, Pages 7-16

  Narten, Maike ^a   Rosin, Nathalie ^a   Schobert, Max ^a   Tielen, Petra ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME AXETIL; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DRUG TOLERANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUTRIENT CONTENT; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BIOFILMS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IRON; MICROBIAL SENSITIVITY TESTS; OXYGEN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOBRAMYCIN; URINARY TRACT; URINARY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84856975088     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-011-0026-y     Document Type: Article

References (53)

1. Anderl JN, Zahller J, Roe F, Stewart PS (2003) Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 47:1251-1256 (Pubitemid 36368581)
2. Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48(Suppl 1):5-16
3. Anwar H, Strap JL, Chen K, Costerton JW (1992) Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother 36:1208-1214
4. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS (2004) Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 48:2659-2664 (Pubitemid 38823439)
5. Breidenstein EB, Khaira BK, Wiegand I, Overhage J, Hancock RE (2008) Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother 52:4486-4491
6. Brooks T, Keevil CW (1997) A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol 24:203-206 (Pubitemid 27149432)
7. Davis RL, Koup JR, Williams-Warren J, Weber A, Smith AL (1985) Pharmacokinetics of three oral formulations of ciprofloxacin. Antimicrob Agents Chemother 28:74-77 (Pubitemid 15029696)
8. de Beer D, Stoodley P, Roe F, Lewandowski Z (1994) Effects of biofilm structures on oxygen distribution and mass transport. Biotechnol Bioeng 43:1131-1138 (Pubitemid 24162411)
9. Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daures JP, Sotto A (2004) Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect 57:209-216 (Pubitemid 38967329)
10. Egberts J, Soederhuizen W (1996) Urine samples before dinner are preferable when studying changes in endogenous nitrate production under uncontrolled dietary conditions. Clin Chim Acta 254:141-148 (Pubitemid 26325563)
11. Ellis G, Adatia I, Yazdanpanah M, Makela SK (1998) Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin Biochem 31:195-220 (Pubitemid 28285351)
12. Fung DK, Chan EW, Chin ML, Chan RC (2010) Delineation of a bacterial starvation stress response network which can mediate antibiotic tolerance development. Antimicrob Agents Chemother 54:1082-1093
13. Giamarellou H (2010) Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents 36(Suppl 2):S50-S54
14. Giannakopoulos X, Evangelou A, Kalfakakou V, Grammeniatis E, Papandropoulos I, Charalambopoulos K (1997) Human bladder urine oxygen content: implications for urinary tract diseases. Int Urol Nephrol 29:393-401 (Pubitemid 27496162)
15. Gilbert P, Collier PJ, Brown MR (1990) Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother 34:1865-1868 (Pubitemid 20290280)
16. Goto T, Nakame Y, Nishida M, Ohi Y (1999) Bacterial biofilms and catheters in experimental urinary tract infection. Int J Antimicrob Agents 11:227-231 discussion 237-239 (Pubitemid 29231965)
17. Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T (2010) An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 59:253-268
18. Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, Hilliard GM, Parvatiyar K, Kamani MC, Wozniak DJ, Hwang SH, McDermott TR, Ochsner UA (2002) Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev 54:1425-1443 (Pubitemid 35375769)
19. Heydorn A, Ersboll BK, Hentzer M, Parsek MR, Givskov M, Molin S (2000) Experimental reproducibility in flow-chamber biofilms. Microbiology 146:2409-2415
20. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322-332
21. Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betlejewska K, Hryniewicz W (2001) Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 47:773-780 (Pubitemid 32519825)
22. Kim J, Hahn JS, Franklin MJ, Stewart PS, Yoon J (2009) Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents. J Antimicrob Chemother 63:129-135
23. Lambert PA (2002) Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 95(Suppl 41):22-26 (Pubitemid 34713187)
24. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48-56 (Pubitemid 44942303)
25. Mah TF, O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34-39 (Pubitemid 32467503)
26. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA (2003) A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310 (Pubitemid 37463151)
27. Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai K (2009) Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health 2:101-111
28. Mittal R, Sharma S, Chhibber S, Harjai K (2008) Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J Biomed Sci 15:731-741
29. Nickel JC, Ruseska I, Wright JB, Costerton JW (1985) Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 27:619-624 (Pubitemid 15097672)
30. Obritsch MD, Fish DN, MacLaren R, Jung R (2004) National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 48:4606-4610 (Pubitemid 39577660)
31. Obritsch MD, Fish DN, MacLaren R, Jung R (2005) Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 25:1353-1364 (Pubitemid 41407633)
32. Palmer KL, Brown SA, Whiteley M (2007) Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J Bacteriol 189:4449-4455 (Pubitemid 46919632)
33. Pascual A, Martinez-Martinez L, Ramirez de Arellano E, Perea EJ (1993) Susceptibility to antimicrobial agents of Pseudomonas aeruginosa attached to siliconized latex urinary catheters. Eur J Clin Microbiol Infect Dis 12:761-765 (Pubitemid 23326556)
34. Plosker GL (2010) Aztreonam lysine for inhalation solution: in cystic fibrosis. Drugs 70:1843-1855
35. Raja NS, Singh NN (2007) Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. J Microbiol Immunol Infect 40:45-49 (Pubitemid 47047137)
36. Rivera-Sanchez R, Delgado-Ochoa D, Flores-Paz RR, Garcia-Jimenez EE, Espinosa-Hernandez R, Bazan-Borges AA, Arriaga-Alba M (2010) Prospective study of urinary tract infection surveillance after kidney transplantation. BMC Infect Dis 10:245
37. Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113(Suppl 1A):14S-19S (Pubitemid 34756641)
38. Rossolini GM, Mantengoli E (2005) Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 11(Suppl 4):17-32 (Pubitemid 40946169)
39. Saha R, Jain S, Kaur IR (2010) Metallo beta-lactamase producing pseudomonas species-a major cause of concern among hospital associated urinary tract infection. J Indian Med Assoc 108:344-348
40. Shigemura K, Arakawa S, Sakai Y, Kinoshita S, Tanaka K, Fujisawa M (2006) Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003). Int J Urol 13:538-542 (Pubitemid 43760416)
41. Silley P, Griffiths JW, Monsey D, Harris AM (1990) Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system. Antimicrob Agents Chemother 34:1806-1808 (Pubitemid 20259520)
42. Spoering AL, Lewis K (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183:6746-6751 (Pubitemid 33064186)
43. Stewart PS, Franklin MJ (2008) Physiological heterogeneity in biofilms. Nat Rev Microbiol 6:199-210 (Pubitemid 351256315)
44. Tenke P, Kovacs B, Jackel M, Nagy E (2006) The role of biofilm infection in urology. World J Urol 24:13-20 (Pubitemid 43298678)
45. Tielen P, Narten M, Rosin N, Biegler I, Haddad I, Hogardt M, Neubauer R, Schobert M, Wiehlmann L, Jahn D (2010) Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections. Int J Med Microbiol 301:282-292
46. Tielen P, Rosenau F, Wilhelm S, Jaeger KE, Flemming HC, Wingender J (2010) Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa. Microbiol 156:2239-2252
47. Tuomanen E, Durack DT, Tomasz A (1986) Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother 30:521-527 (Pubitemid 16030691)
48. van Delden C (2004) Virulence factors in Pseudomonas aeruginosa. In: Ramos JL (ed) Pseudomonas. Kluwer Academics/Plenum Publisher, New York, pp 3-46
49. van Poppel H, Chysky V, Hullmann R, Baert L (1988) Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review. Infection 16:337-344 (Pubitemid 19004304)
50. Waite RD, Papakonstantinopoulou A, Littler E, Curtis MA (2005) Transcriptome analysis of Pseudomonas aeruginosa growth: comparison of gene expression in planktonic cultures and developing and mature biofilms. J Bacteriol 187:6571-6576 (Pubitemid 41318418)
51. Wang J, Brown MA, Tam SH, Chan MC, Whitworth JA (1997) Effects of diet on measurement of nitric oxide metabolites. Clin Exp Pharmacol Physiol 24:418-420 (Pubitemid 27244855)
52. Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A, Molin S, Pitts B, Stewart PS (2004) Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 70:6188-6196 (Pubitemid 39471869)
53. Zhao Z, Ma Y, Dai C, Zhao R, Li S, Wu Y, Cao Z, Li W (2009) Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother 53:3472-3477